Translational correlates, including outcome for patients (pts) with ER-/PR-/HER2- (triple negative (TNeg)) disease from N0234, a phase II trial of gemcitabine and erlotinib for pts with previously treated metastatic breast cancer (MBC)
- Citation:
- J Clin Oncol vol 25 (18s) abstr 1071
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 177
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. Thome T. Hobday D. Hillman M. Aubry W. Lingle M. Reinholz D. Graham P. Flynn A. Moreno E. Perez
- Networks:
- Study
- NCCTG-N0234
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: